Symbiox Investment & Trading Co Ltd Stock Price Today (NSE: SYMBIOX)
Fundamental Score
Symbiox Investment & Trading Co Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Symbiox Investment & Trading Co Ltd share price today is ₹1.95, up +0.00% on NSE/BSE as of 22 September 2026. Symbiox Investment & Trading Co Ltd (SYMBIOX) is a Small-cap company in the Other Financial Services sector with a market capitalisation of ₹4.98 (Cr). The 52-week high for SYMBIOX share price is ₹3.70 and the 52-week low is ₹1.36. At a P/E ratio of 33.19x, SYMBIOX is currently trading above its industry average P/E of 27.57x. The company has a Return on Equity (ROE) of 0.47% and a debt-to-equity ratio of 0.00.
Symbiox Investment & Trading Co Ltd Share Price Chart — NSE/BSE Historical Performance
Symbiox Investment & Trading Co Ltd share price chart: 19.16% return over the past month. 52-week high ₹3.70, 52-week low ₹1.36.
Symbiox Investment & Trading Co Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹2.01 | ₹2.01 | ₹1.99 | ₹1.99 | 15.54K (Cr) | |
| ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 | 1.30K (Cr) | |
| ₹2.00 | ₹2.00 | ₹1.72 | ₹2.00 | 15.46K (Cr) | |
| ₹2.01 | ₹2.13 | ₹2.00 | ₹2.00 | 4.03K (Cr) | |
| ₹2.06 | ₹2.06 | ₹2.00 | ₹2.00 | 8.89K (Cr) | |
| ₹2.01 | ₹2.08 | ₹2.01 | ₹2.06 | 5.01K (Cr) | |
| ₹2.02 | ₹2.02 | ₹1.99 | ₹2.01 | 13.27K (Cr) | |
| ₹2.15 | ₹2.15 | ₹1.91 | ₹1.99 | 2.92K (Cr) | |
| ₹2.00 | ₹2.00 | ₹1.83 | ₹1.83 | 9.56K (Cr) | |
| ₹2.01 | ₹2.01 | ₹1.81 | ₹2.00 | 22.54K (Cr) |
Symbiox Investment & Trading Co Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹1.68 | ₹2.15 | ₹1.60 | ₹1.99 | +18.45% | |
| ₹1.56 | ₹1.73 | ₹1.48 | ₹1.70 | +8.97% | |
| ₹1.73 | ₹1.87 | ₹1.52 | ₹1.56 | -9.83% | |
| ₹1.78 | ₹1.90 | ₹1.66 | ₹1.73 | -2.81% | |
| ₹1.46 | ₹2.07 | ₹1.36 | ₹1.77 | +21.23% | |
| ₹1.72 | ₹1.89 | ₹1.46 | ₹1.46 | -15.12% | |
| ₹1.84 | ₹2.19 | ₹1.70 | ₹1.86 | +1.09% | |
| ₹1.72 | ₹2.07 | ₹1.64 | ₹1.85 | +7.56% | |
| ₹2.77 | ₹2.94 | ₹1.81 | ₹1.81 | -34.66% | |
| ₹2.98 | ₹3.10 | ₹2.75 | ₹2.77 | -7.05% | |
| ₹2.70 | ₹3.70 | ₹2.15 | ₹2.98 | +10.37% | |
| ₹2.65 | ₹2.89 | ₹2.65 | ₹2.80 | +5.66% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Assets (ROA)
Bank profit generated relative to total assets
Net Profit Margin
Net profit as a percentage of reported revenue/income
Dividend Yield
Annual dividend as % of current share price
Symbiox Investment & Trading Co Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Price to Book (P/B)
Share price ÷ book value per share — key bank valuation metric
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt/Equity, interest coverage and industrial free-cash-flow ratios are not shown for banks because deposits and borrowings are part of the core lending business. Bull Run uses ROA, ROE, P/B and net profit margin above for bank analysis.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Symbiox Investment & Trading Co Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of SYMBIOX across key market metrics for learning purposes.
Positive Indicators
4 factors identified
Robust Profit Growth (103.33%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Excellent EPS Growth (16.47% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (16.47% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
6 factors identified
Below-Average Return on Equity (0.47%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (0.66%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Revenue Contraction (-33.60%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Limited Growth History (-5.11% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Low Promoter Commitment (3.33%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Symbiox Investment & Trading Co Ltd vs Other Financial Services Peers
Peer Comparison - Other Financial Services
Compare Symbiox Investment & Trading Co Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Symbiox Investment & Trading Co LtdSymbiox Investm...Selected✓ SYMBIOX • 539278 | 23.9/100 | ₹1.95₹2 | ₹4.98₹4.98 | 33.19Average 33.2 Average | 0.47%Poor 0.47% Poor | 0.66%Poor 0.66% Poor | 0.00Excellent 0.0 Excellent | 16.47%Excellent 16.47% Excellent | -5.11%Poor -5.11% Poor | 0.00% |
Crisil LimitedCrisil Limited... CRISIL • 500092 | 66.4/100 | ₹4745.90₹4746 | ₹34692.53₹34692.53 | 39.25Average 39.2 Average | 27.37%Excellent 27.37% Excellent | — — | — — | 14.40%Good 14.40% Good | 12.99%Good 12.99% Good | 0.59% |
RRPSemiconductorRRPSemiconducto... RRPS • 504346 | 8/100 | ₹15.00₹15 | ₹12118.00₹12118.00 | — — | -61.01%Poor -61.01% Poor | — — | — — | — — | — — | 0.00% |
Dhani Services LtdDhani Services ... DHANI • 532960 | 20.9/100 | ₹51.06₹51 | ₹3896.81₹3896.81 | 114.92Average 114.9 Average | -1.81%Poor -1.81% Poor | 1.39%Poor 1.39% Poor | 0.18Excellent 0.2 Excellent | — — | -32.89%Poor -32.89% Poor | 0.00% |
COLAB PLATFORMS LIMITEDCOLAB PLATFORMS... COLAB • 542866 | 45/100 | ₹132.40₹132 | ₹2700.96₹2700.96 | 553.76Average 553.8 Average | 17.57%Good 17.57% Good | — — | — — | 198.76%Excellent 198.76% Excellent | 356.32%Excellent 356.32% Excellent | 0.01% |
Algoquant Fintech LimitedAlgoquant Finte... ALGOQUANT • 505725 | 57.7/100 | ₹63.96₹64 | ₹1797.89₹1797.89 | 45.69Average 45.7 Average | 27.69%Excellent 27.69% Excellent | — — | — — | 67.14%Excellent 67.14% Excellent | 111.83%Excellent 111.83% Excellent | 0.00% |
LKP Finance LtdLKP Finance Ltd... LKPFIN • 507912 | 53.9/100 | ₹189.35₹189 | ₹1251.64₹1251.64 | 57.39Average 57.4 Average | 5.24%Poor 5.24% Poor | 6.77%Poor 6.77% Poor | 0.00Excellent 0.0 Excellent | -18.20%Poor -18.20% Poor | 31.70%Excellent 31.70% Excellent | 0.00% |
Centrum Capital LimitedCentrum Capital... CENTRUM • 501150 | 0/100 | ₹22.33₹22 | ₹1087.09₹1087.09 | — — | -46.79%Poor -46.79% Poor | — — | — — | — — | 49.72%Excellent 49.72% Excellent | 0.00% |
Prime Securities LimitedPrime Securitie... PRIMESECU • 500337 | 35.4/100 | ₹279.00₹279 | ₹946.93₹946.93 | 169.09Average 169.1 Average | 6.69%Poor 6.69% Poor | — — | — — | 2.90%Average 2.90% Average | 25.66%Excellent 25.66% Excellent | 0.54% |
85/100 | ₹852.90₹853 | ₹908.76₹908.76 | 27.51Average 27.5 Average | 27.72%Excellent 27.72% Excellent | — — | — — | 24.61%Excellent 24.61% Excellent | 23.58%Excellent 23.58% Excellent | 2.10% | |
63.7/100 | ₹322.55₹323 | ₹614.86₹614.86 | 21.22Average 21.2 Average | 20.57%Excellent 20.57% Excellent | 27.26%Excellent 27.26% Excellent | 0.17Excellent 0.2 Excellent | 31.11%Excellent 31.11% Excellent | 48.53%Excellent 48.53% Excellent | 0.00% | |
Top Other Financial Services Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Crisil Limited share price34692.53 Cr
- RRPSemiconductor share price12118.00 Cr
- Dhani Services Ltd share price3896.81 Cr
- COLAB PLATFORMS LIMITED share price2700.96 Cr
- Algoquant Fintech Limited share price1797.89 Cr
Symbiox Investment & Trading Co Ltd PE Ratio History
Historical price-to-earnings ratio for SYMBIOX — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹0.06 | ₹1.81 | 29.7x |
| FY 2024 | ₹0.07 | ₹5.42 | 80.9x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Symbiox Investment & Trading Co Ltd Quarterly Performance
Latest quarterly metrics for SYMBIOX — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
-33.60%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
103.33%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
-5.11%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
16.47%
Compounded annual net profit growth over 5 years
Symbiox Investment & Trading Co Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for SYMBIOX — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Symbiox Investment & Trading Co Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Symbiox Investment & Trading Co Ltd (SYMBIOX) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for Symbiox Investment & Trading Co Ltd
About SYMBIOX (Symbiox Investment & Trading Co Ltd)
Symbiox Investment & Trading Co Ltd is a dynamic entity operating within the Other Financial Services sector, actively cultivating a diversified portfolio of strategic investments ...and trade-related activities. The company distinguishes itself through its nimble approach to identifying and capitalizing on emerging market opportunities, driven by in-depth market research and a commitment to fostering sustainable growth. Symbiox operates with a focus on building strong partnerships and leveraging its extensive network to facilitate seamless transactions and maximize value creation across its varied ventures. The company is committed to adhering to the highest standards of ethical conduct and regulatory compliance, ensuring transparency and accountability in all its business dealings. At the core of Symbiox’s operations lies a commitment to fostering financial innovation and efficiency. The company actively explores and integrates cutting-edge technologies and methodologies to optimize its investment strategies and streamline its trading processes. This proactive approach enables Symbiox to adapt quickly to evolving market dynamics and maintain a competitive edge in the ever-changing financial landscape. Furthermore, Symbiox recognizes the importance of nurturing talent and fostering a collaborative work environment. The company invests in its employees, providing them with opportunities for professional development and empowering them to contribute to the company's overall success. Symbiox Investment & Trading Co Ltd distinguishes itself through its commitment to delivering exceptional value to its stakeholders. By combining a strategic focus on identifying lucrative investment opportunities with a dedication to operational excellence, the company strives to generate consistent and sustainable returns. Symbiox is dedicated to upholding the highest standards of integrity and ethical conduct in all its business dealings. By prioritizing transparency, accountability, and responsible corporate citizenship, Symbiox aims to build long-term trust and strong relationships with its partners, clients, and the broader community.
Company Details
Key Leadership
SYMBIOX Share Price: Frequently Asked Questions
What is the current share price of Symbiox Investment & Trading Co Ltd?
Symbiox Investment & Trading Co Ltd (SYMBIOX) trades at ₹1.95 on NSE and BSE. Market cap ₹4.98 (Cr). Educational data only.
What is the P/E ratio of Symbiox Investment & Trading Co Ltd?
Symbiox Investment & Trading Co Ltd has a P/E of 33.19x vs industry average 27.57x.
What is the Bull Run score for Symbiox Investment & Trading Co Ltd?
Symbiox Investment & Trading Co Ltd has a Bull Run score of 23.9/100 based on 25+ financial parameters.
Does Symbiox Investment & Trading Co Ltd pay dividends?
Symbiox Investment & Trading Co Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Symbiox Investment & Trading Co Ltd?
Symbiox Investment & Trading Co Ltd has ROE of 0.47%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Symbiox Investment & Trading Co Ltd?
Symbiox Investment & Trading Co Ltd has debt-to-equity of 0.00.
Is Symbiox Investment & Trading Co Ltd a good investment?
Bull Run gives Symbiox Investment & Trading Co Ltd a score of 23.9/100. This is not investment advice — consult a SEBI-registered advisor.